Search

everythinglearnresearchcommunity

for

Search:↓

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Certain gene combinations may affect prostate cancer risk, and GSTP1 methylation is linked to tumor aggressiveness.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

FDG PET/CT scans can change cancer treatment plans for dogs.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Controlling cellular changes can enable safe rejuvenation without cancer risk.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Certain blood markers can help predict and manage chemotherapy side effects in older cancer patients.

Early detection and a multidisciplinary approach are crucial for improving gastric cancer survival rates.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Certain microRNAs found in normal cells can effectively suppress various cancers.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

Adding a second method to PROTACs could improve cancer treatment.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

Genosomes are promising for safe and effective gene delivery in therapy.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Understanding where cancer cells come from helps create better prevention and treatment methods.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Combining genetic and physical trait analysis improves diagnosis accuracy for monogenic diabetes.

The new AI software predicts melanoma outcomes more accurately than traditional methods.